CNS Pharmaceuticals (CNSP) - חוב לטווח ארוך להון

CNS Pharmaceuticals (CNSP) is implementing robotic bioscreening systems, which accelerates drug discovery and relieves scientists of monotonous work. This price chart illustrates the dynamics of the asset, which has a value of 0.00. The business relies on the development of targeted therapy; meanwhile, financial stability currently depends on medical test outcomes, as the company is in the clinical trial stage.

This indicator assesses the dependence of long-term liabilities on the equity and market value of CNS Pharmaceuticals (CNSP). The calculation is based on the ratio of loans with a maturity exceeding one year to total capitalization. The dynamics of long-term debt financial leverage reflect the stability of the financing structure. A stable chart confirms the company's ability to maintain optimized logistics for oncology drugs. This guarantees the uninterrupted supply of substances even amidst volatile market prices.